We’re leveraging advances in genetics and precision medicine to develop new therapeutics that target shared, underlying biology in rare and common diseases — bringing meaningful medicines from one to many. 

With expertise in genetics, drug discovery and data sciences, we seek to identify programs where both biological and technical risk can be minimized to streamline the drug development process and bring forward exceptionally potent and precisely targeted therapeutics for patients. 

Biotechnology

Health Care

Life Sciences

Pharmaceutical

Actio Biosciences, Inc.

David B. Goldstein

Adriana Caraveo

Samuel Collins

Zhong Ren

John Mchutchison

Anne Sandan

David Breckenridge

Actio Biosciences, Inc.

Org chart

Similar companies